Get started
Author

Jessica Y. Hsieh

Observed name: Jessica Hsieh
ORCID: 0000-0002-3622-9531
Observed ORCID: 0000-0002-3622-9531
OpenAlex ID: A5078998456
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
2019 · Lawrence Fong, Andrew Hotson, et al. · Cancer Discovery · 363
YAP-mediated mechanotransduction tunes the macrophage inflammatory response
2020 · Vijaykumar S. Meli, Hamza Atcha, et al. · Science Advances · 350
PDF
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
2018 · Stephen B. Willingham, Po Y. Ho, et al. · Cancer Immunology Research · 228
Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen
2016 · Jessica Y. Hsieh, Tim D. Smith, et al. · Acta Biomaterialia · 219
PDF
Matrix crosslinking enhances macrophage adhesion, migration, and inflammatory activation
2019 · Jessica Y. Hsieh, Mark T. Keating, et al. · APL Bioengineering · 91
Incorporation of a Ligand Peptide for Immune Inhibitory Receptor LAIR‐1 on Biomaterial Surfaces Inhibits Macrophage Inflammatory Responses
2017 · Yoon Kyung Kim, Shu‐Hui Chu, et al. · Advanced Healthcare Materials · 22
Characterization and Phase 1 Trial of a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
2020 · Stephen B. Willingham, Gerard Criner, et al. · medRxiv · 8
PDF
Abstract A044: Screening and characterization of CD38 chimeric antigen receptors for the development of natural killer cell-based therapies
2023 · Emily N Kang, Jacinda T Chen, et al. · Cancer Immunology Research · 2
Supplementary Data from Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
2023 · Lawrence Fong, Andrew Hotson, et al.
Data from Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
2023 · Lawrence Fong, Andrew Hotson, et al.
Data from A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
2023 · Stephen B. Willingham, Po Y. Ho, et al.
Supplementary Data from A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
2023 · Stephen B. Willingham, Po Y. Ho, et al.
Supplementary Data from A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
2023 · Stephen B. Willingham, Po Y. Ho, et al.
Data from A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
2023 · Stephen B. Willingham, Po Y. Ho, et al.
Data from Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
2023 · Lawrence Fong, Andrew Hotson, et al.
Mechanochemical Regulation of Macrophage Inflammatory Activation by Fibrin(ogen)
2018 · Jessica Hsieh · eScholarship (California Digital Library)
PDF
Works count: 16
Citation count: 1,283
H-index: 7
I10-index: 6
Year
Topic
Type